Forgot Password »

Request Access »

(PETALNet members only)

Clinicians & Researchers

You are here

Who We Are

The Clinical Trials Network for the Prevention and Early Treatment of Acute Lung Injury (PETAL Network) is a network of 12 Clinical Centers (CC) and 1 Clinical Coordinating Center (CCC) funded by the National Heart, Lung, and Blood Institute (NHLBI) to develop and conduct randomized controlled clinical trials to prevent Acute Respiratory Distress Syndrome (ARDS) or provide early treatment to improve the outcome of patients who have ARDS. The PETAL Network is seeking your input and feedback.

Community Outreach Project

The PETAL Network welcomes future prevention and early treatment trial ideas from the US and international acute care and critical care community.

Please enter your comments and ideas here:

IPC Committee

Thompson, B. Taylor, MD (Chair) Massachusetts General Hospital (CCC)
Angus, Derek C, MD UPMC Presbyterian
Bienstock, Karen, PA-C NHLBI
Gong, Michelle Ng, MD Montefiore Moses
Hou, Peter C, MD Brigham and Women's Hospital
Park, Pauline K, MD University of Michigan Medical Center
Shapiro, Nate, MD Beth Israel Medical Center
Steingrub, Jay S, MD Baystate Medical Center
Talmor, Daniel, MD Beth Israel Medical Center
Thompson, B. Taylor, MD Massachusetts General Hospital (CCC)
Yealy, Donald M, MD UPMC Presbyterian

An international advisory committee (IAC) has also been formed to facilitate dialog and coordination of research efforts with US and international experts and other clinical trials groups. Plans for their first meeting are in process. Please check back here for updates on their activities.

News & Announcements

Dec 17, 2015

It is with the heaviest of hearts and deepest sorrow that the PETAL Network notes the passing of Arthur “Art” P. Wheeler on December 17th, 2015.

read more…

Jul 7, 2015

On May 20th, PETAL Network investigators presented an update on the Network's activities to attendees of the American Thoracic Society's 2015 International Meeting held in Denver Colorado.
Highlights from the presentation:

Sep 24, 2014

Statin therapy does not prevent exacerbations of chronic obstructive pulmonary disease (COPD) or lower mortality from acute respiratory distress syndrome (ARDS), report two studies that rigorously tested the benefit of the cholesterol-lowering drugs on outcomes in the lung diseases.